Search bioRxiv⌕ Search

Biology subjects

Afroz, J.

Publications and source records attributed to Afroz, J..

2 recordsLinked to original sources

Multimodal protein representations across human brain cell types

The central nervous system (CNS) comprises diverse cell types whose molecular context shapes the roles of the proteins they express. Computational models offer a scalable way to study the roles of proteins across human brain cell types, with protein language models and interactome- or single-cell-based models capturing complementary information encoded in protein sequences and cellular network contexts. Human brain tissue is hard to access, so brain cell types make up a small fraction of the atlases single-cell models train on and of the benchmarks used for their evaluation. To capture these complementary sources of information in the CNS, we introduce SEMPER, a multimodal representation learning model that aligns protein language model representations with protein-protein interaction networks from 442 cell types of the adult human brain, giving each protein a sequence-informed representation in every cell type in which its gene is expressed. We show that SEMPER representations predict cell type-specific protein complexes and predict genes essential to the survival of dopaminergic neurons, measured in a genome-wide CRISPR screen. In zero-shot retrieval, SEMPER recovers clinically pursued drug targets for Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington's disease and amyotrophic lateral sclerosis at higher rates than cell type-specific models. To further improve target recovery, we combine SEMPER with a large language model that reasons over protein functional annotations. The combination recovers more targets, with SEMPER providing experimentally derived cellular context that complements literature-based reasoning of the large language model.

bioinformatics↗

NERINE reveals rare variant associations in gene networks across multiple phenotypes and implicates an SNCA-PRL-LRRK2 subnetwork in Parkinson's disease

There are two primary approaches to study the genetic basis of human phenotypes. Experiments in model systems generate interpretable gene networks but, in isolation, do not establish relevance to the human condition. Statistical genetics identifies relevant association signals at the variant or gene level but lacks tools to test specific mechanistic models, as existing methods do not incorporate the topology of gene-gene interactions. We bridge these two strategies by introducing a method that competitively tests network hypotheses with rare variant associations. A hierarchical model-based association test NERINE for the first time incorporates gene network topology while remaining resilient to network inaccuracies. We demonstrate NERINEs ability to test network hypotheses derived from both canonical pathway databases and model system screens. Comprehensive database-wide search of pathway networks with NERINE uncovers compelling associations for breast cancer, cardiovascular diseases, and type II diabetes, which are undetected by single-gene tests. Testing bespoke networks from experimental screens targeting key PD pathologies: dopaminergic neuron survival and -synuclein pathobiology, NERINE highlights rare variant burden in gene modules related to autophagy, vesicle traiicking, and protein homeostasis. Genome-scale CRISPRi-screening of -synuclein toxicity modifiers in human neurons and NERINE converge on PRL, revealing an intraneuronal -synuclein/prolactin stress response that may impact resilience to PD pathologies.

genetics↗